GreenCyclePallets
Pharmaceutical

Pharmaceutical Company Meets FDA Compliance with Custom Pallets

BioVita Labs
200+ employees
South San Francisco, CA
Timeline: 10 weeks from emergency response to successful FDA follow-up inspection
The Challenge

What BioVita Labs Was Facing

BioVita Labs, a mid-size pharmaceutical manufacturer specializing in injectable biologics and temperature-sensitive vaccines, faced a regulatory crisis when an FDA inspection of their South San Francisco packaging and distribution facility identified critical deficiencies in their pallet management practices. The inspection report cited three observations: the absence of documented pallet sanitation protocols, the use of pallets with visible mold contamination in a controlled environment, and the lack of traceability records linking specific pallet lots to outbound pharmaceutical shipments. The FDA issued a Form 483 with these observations and gave BioVita 30 days to submit a corrective action plan. The stakes were enormous -- failure to adequately address the observations could result in a Warning Letter, which would jeopardize BioVita's ability to ship product and could trigger a review of their manufacturing license. The company had $47 million in pending shipments of a time-sensitive biologic product that required distribution within a 90-day window, and any shipping hold would result in product expiration and total loss. BioVita's existing pallet supplier, a general-purpose wood products company, had no capability to provide the documentation, traceability, or sanitation standards required for pharmaceutical distribution. The supplier could not certify moisture content levels, had no heat treatment verification process, and offered no lot tracking system. BioVita's quality assurance team determined they needed a pallet partner who understood cGMP (current Good Manufacturing Practice) requirements and could provide pharmaceutical-grade pallets with full documentation.

Our Solution

How GreenCycle Solved It

GreenCycle Pallets mobilized an emergency response team within 48 hours of BioVita's initial call, recognizing the urgency of the FDA timeline. GreenCycle's pharmaceutical pallet program -- developed in collaboration with quality consultants experienced in FDA-regulated environments -- was adapted specifically to BioVita's biologics distribution requirements. The program centered on three pillars: sanitation, traceability, and documentation. Every pallet supplied to BioVita undergoes GreenCycle's PharmaPallet process: kiln drying to a verified moisture content below 19% (preventing mold growth), ISPM-15 compliant heat treatment at a core temperature of 56 degrees Celsius for 30 minutes (eliminating biological contaminants), and a final inspection under UV light for any residual contamination. Each pallet receives a unique lot number laser-etched into the lead board, linking it to a digital Certificate of Compliance that documents treatment parameters, moisture readings, inspection results, and chain of custody from GreenCycle's facility to BioVita's receiving dock. GreenCycle also helped BioVita develop Standard Operating Procedures (SOPs) for pallet receiving inspection, storage, and rotation within the controlled warehouse environment. These SOPs were incorporated into BioVita's quality management system and included in the corrective action plan submitted to the FDA. GreenCycle's quality team participated in a mock audit with BioVita prior to the FDA's follow-up inspection, ensuring all documentation and processes would withstand regulatory scrutiny.

Implementation

Phase-by-Phase Timeline

1

Phase 1: Emergency Assessment & Response

1 week

GreenCycle deployed a two-person assessment team to BioVita's facility within 48 hours. Conducted a full audit of existing pallet inventory, identified and quarantined 340 pallets with visible contamination, and replaced them with certified PharmaPallet units from emergency stock. Drafted initial corrective action framework for FDA response.

2

Phase 2: SOP Development & Staff Training

3 weeks

Collaborated with BioVita's QA team to develop five new SOPs covering pallet receiving inspection, controlled storage conditions, lot traceability documentation, contamination response procedures, and supplier qualification requirements. Trained 28 warehouse and quality personnel on the new protocols.

3

Phase 3: Full Program Deployment

4 weeks

Transitioned BioVita's entire pallet inventory to GreenCycle PharmaPallet units with full lot traceability. Integrated GreenCycle's digital Certificate of Compliance system with BioVita's electronic batch record system, enabling automatic pallet-to-shipment linkage. Established a dedicated production schedule at GreenCycle's facility to ensure 72-hour lead times on BioVita orders.

4

Phase 4: FDA Audit Preparation & Follow-Up

2 weeks

Conducted two mock audits simulating FDA inspection protocols. Compiled a comprehensive corrective action evidence package including six weeks of traceability records, treatment verification certificates, and environmental monitoring data. Supported BioVita through the successful FDA follow-up inspection with zero repeat observations.

Results

Measurable Impact

Metric
Before
After
Improvement
FDA Compliance Status
Form 483 (3 observations)
Full compliance, zero observations
+All observations resolved
Pallet Contamination Incidents
12 per quarter
0 per quarter
+100% elimination
Shipment Traceability
No pallet-to-shipment linkage
100% lot-level traceability
+Full chain of custody
Product at Risk (Pending Shipments)
$47M in jeopardy
$0 at risk
+All shipments released on schedule
Pallet Moisture Content
Uncontrolled (22-35%)
Certified below 19%
+Meets pharmaceutical standards
Key Benefits

What BioVita Labs Gained

  • Resolved all three FDA Form 483 observations within the 30-day corrective action window
  • Protected $47 million in time-sensitive biologic product shipments from regulatory hold
  • Established pharmaceutical-grade pallet specifications with full cGMP documentation
  • Implemented 100% lot-level pallet traceability integrated with electronic batch records
  • Eliminated pallet-related contamination incidents entirely through controlled moisture and heat treatment
  • Developed reusable SOP framework that strengthened BioVita's overall quality management system
When the FDA cited us on pallet contamination, we had 30 days and $47 million in product on the line. GreenCycle had a team in our facility within two days, and within a week we had quarantined every non-compliant pallet and started receiving certified replacements. Their PharmaPallet documentation system is exactly what the FDA wanted to see. We passed the follow-up inspection with flying colors.

Dr. Sarah Patel

Director of Quality Assurance, BioVita Labs

Get Similar Results for Your Business

Every partnership starts with understanding your unique needs. Fill out the form below and our team will reach out within 24 hours with a tailored plan.

US/Canada format: (555) 123-4567

US: 12345 or 12345-6789 | CA: A1A 1A1